NIO

NIO Inc.

56
Fundamentals77/ 100
Valuation50/ 100
Upside potential58/ 100
Risk potential27/ 100

NIO has the edge over SHOE overall, supported by stronger fundamentals and stronger valuation.

SHOE

Shoe Station Group Inc.

32
Fundamentals35/ 100
Valuation20/ 100
Upside potential33/ 100
Risk potential46/ 100

SHOE's outlook is improving despite an expensive valuation.

NIO Fundamentals

MetricStatus
Strong
Stable
Stable
Unavailable

NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.

SHOE Fundamentals

MetricStatus
Stable
Stable
Healthy
Strong

SHOE's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.

NIO PE Valuation

NIO has no meaningful PE right now: it lost money over the past year.

SHOE PE Valuation

CHEAPFAIREXPENSIVE18x36x54x72x
CHEAPFAIREXPENSIVE18x36x54x72x
LevelPEPriceVs current
Cheap6.3x$5.57-61%
Fair9.2x$8.12-43%
Forward10x$14.20—
Expensive15x$13.27-6.5%
Current16x$14.20—

Historical ranges are pointers, not guarantees.

SHOE's PE is in its expensive range at 16x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its fair range.

NIO Forward outlook

MetricOutlook
--
Losses shrinking
Growth
Strongly improving
Limited
Moderate

NIO has the edge over SHOE on the outlook, with more favorable revenue expectations.

SHOE Forward outlook

MetricOutlook
Strongly improving
Growth
Stable
Improving
Limited
High

Analysts expect SHOE's earnings to grow and its profitability to improve, with its revenue holding steady.

NIO Risk to reward

ScenarioChangePrice
Upside+38%$4.21
Downside-27%$2.22

Calculated from the latest close: $3.05 on Nov 12.

NIO has a better modeled risk to reward balance than SHOE, with more potential upside and less potential downside.

SHOE Risk to reward

ScenarioChangePrice
Upside+23%$17.40
Downside-46%$7.72

Calculated from the latest close: $14.20 on Nov 12.

SHOE trails NIO on modeled risk to reward, with less potential upside and more potential downside.

NIO Earnings Per Share

Q3 2023: $-1.93Q4 2023: $-1.87Q1 2024: $-1.82Q2 2024: $-1.64Q3 2024: $-1.61Q4 2024: $-1.66Q1 2025: $-1.76Q2 2025: $-1.74Q3 2025: $-1.59Q4 2025: $-1.06Q1 2026: $-0.60Q2 2026: $-0.29
Q3 2023: $-1.93Q4 2023: $-1.87Q1 2024: $-1.82Q2 2024: $-1.64Q3 2024: $-1.61Q4 2024: $-1.66Q1 2025: $-1.76Q2 2025: $-1.74Q3 2025: $-1.59Q4 2025: $-1.06Q1 2026: $-0.60Q2 2026: $-0.29
QuarterTTM EPSYoY
Q2 2026-$0.29+$1.45
Q1 2026-$0.60+$1.16
Q4 2025-$1.06+$0.60
Q3 2025-$1.59+$0.02
Q2 2025-$1.74-$0.10
Q1 2025-$1.76+$0.06
Q4 2024-$1.66+$0.21
Q3 2024-$1.61+$0.32

NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.

SHOE Earnings Per Share

Q4 2023: $2.90Q1 2024: $2.68Q2 2024: $2.71Q3 2024: $2.82Q4 2024: $2.72Q1 2025: $2.68Q2 2025: $2.39Q3 2025: $2.27Q4 2025: $2.10Q1 2026: $1.90Q2 2026: $1.35Q3 2026: $0.88Forward: $1.39
Q4 2023: $2.90Q1 2024: $2.68Q2 2024: $2.71Q3 2024: $2.82Q4 2024: $2.72Q1 2025: $2.68Q2 2025: $2.39Q3 2025: $2.27Q4 2025: $2.10Q1 2026: $1.90Q2 2026: $1.35Q3 2026: $0.88Forward: $1.39
QuarterTTM EPSYoY
Forward$1.39+58%
Q3 2026$0.88-61%
Q2 2026$1.35-44%
Q1 2026$1.90-29%
Q4 2025$2.10-23%
Q3 2025$2.27-20%
Q2 2025$2.39-12%
Q1 2025$2.680%
Q4 2024$2.72-6.2%

SHOE has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.

NIO Quarterly Revenue

Q3 2023: $2.9BQ4 2023: $2.6BQ1 2024: $1.5BQ2 2024: $2.6BQ3 2024: $2.8BQ4 2024: $3BQ1 2025: $1.8BQ2 2025: $2.9BQ3 2025: $3.3BQ4 2025: $5.2BQ1 2026: $3.8BQ2 2026: $4.8B
Q3 2023: $2.9BQ4 2023: $2.6BQ1 2024: $1.5BQ2 2024: $2.6BQ3 2024: $2.8BQ4 2024: $3BQ1 2025: $1.8BQ2 2025: $2.9BQ3 2025: $3.3BQ4 2025: $5.2BQ1 2026: $3.8BQ2 2026: $4.8B
QuarterRevenueYoY
Q2 2026$4.8B+69%
Q1 2026$3.8B+112%
Q4 2025$5.2B+76%
Q3 2025$3.3B+17%
Q2 2025$2.9B+9%
Q1 2025$1.8B+21%
Q4 2024$3B+15%
Q3 2024$2.8B-2.1%

NIO has the edge over SHOE on sales, with more consistent year-over-year improvement.

SHOE Quarterly Revenue

Q4 2023: $320MQ1 2024: $280MQ2 2024: $300MQ3 2024: $333MQ4 2024: $307MQ1 2025: $263MQ2 2025: $278MQ3 2025: $306MQ4 2025: $297MQ1 2026: $254MQ2 2026: $271MQ3 2026: $284M
Q4 2023: $320MQ1 2024: $280MQ2 2024: $300MQ3 2024: $333MQ4 2024: $307MQ1 2025: $263MQ2 2025: $278MQ3 2025: $306MQ4 2025: $297MQ1 2026: $254MQ2 2026: $271MQ3 2026: $284M
QuarterRevenueYoY
Q3 2026$284.3M-7.2%
Q2 2026$270.7M-2.5%
Q1 2026$254.1M-3.4%
Q4 2025$297.2M-3.2%
Q3 2025$306.4M-7.9%
Q2 2025$277.7M-7.5%
Q1 2025$262.9M-6.1%
Q4 2024$306.9M-4.1%

SHOE's revenue has slid since its 2021 peak: $284M last quarter, down 7.2% from the same quarter a year ago.

NIO Free Cash Flow

Q3 2023: --Q4 2023: $137MQ1 2024: $0Q2 2024: −$2.2BQ3 2024: $0Q4 2024: −$391MQ1 2025: $0Q2 2025: −$2.1BQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Q3 2023: --Q4 2023: $137MQ1 2024: $0Q2 2024: −$2.2BQ3 2024: $0Q4 2024: −$391MQ1 2025: $0Q2 2025: −$2.1BQ3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
QuarterFree cash flowYoY
Q2 2026$0+$2.1B
Q1 2026$0$0
Q4 2025$0+$391.3M
Q3 2025$0$0
Q2 2025-$2.1B+$73.9M
Q1 2025$0$0
Q4 2024-$391.3M-386%
Q2 2024-$2.2B+$337.9M

NIO has the edge over SHOE on cash flow, with more consistent year-over-year improvement.

SHOE Free Cash Flow

Q4 2023: $34MQ1 2024: $41MQ2 2024: $7MQ3 2024: $18MQ4 2024: $8MQ1 2025: $36MQ2 2025: −$23MQ3 2025: $2MQ4 2025: $20MQ1 2026: $28MQ2 2026: $13MQ3 2026: $7M
Q4 2023: $34MQ1 2024: $41MQ2 2024: $7MQ3 2024: $18MQ4 2024: $8MQ1 2025: $36MQ2 2025: −$23MQ3 2025: $2MQ4 2025: $20MQ1 2026: $28MQ2 2026: $13MQ3 2026: $7M
QuarterFree cash flowYoY
Q3 2026$6.5M+197%
Q2 2026$12.6M+$35.6M
Q1 2026$27.7M-24%
Q4 2025$19.7M+138%
Q3 2025$2.2M-88%
Q2 2025-$23M-435%
Q1 2025$36.2M-11%
Q4 2024$8.3M-76%

SHOE still generates free cash flow, though less than at its 2021 peak: $67M over the past year.

NIO Total Shares

Q3 2023: 1.7BQ4 2023: 1.8BQ1 2024: 2BQ2 2024: 2BQ3 2024: 2.1BQ4 2024: 2.1BQ1 2025: 2.1BQ2 2025: 2.2BQ3 2025: 2.4BQ4 2025: 2.5BQ1 2026: 2.5BQ2 2026: 2.5B
Q3 2023: 1.7BQ4 2023: 1.8BQ1 2024: 2BQ2 2024: 2BQ3 2024: 2.1BQ4 2024: 2.1BQ1 2025: 2.1BQ2 2025: 2.2BQ3 2025: 2.4BQ4 2025: 2.5BQ1 2026: 2.5BQ2 2026: 2.5B
PeriodChange %Net change
Quarterly+0.6%+15.6M shares
1 year+12%+267M shares
3 years+51%+844M shares
5 years+60%+933M shares
Available history+143%+1.5B shares

NIO has 2.5B diluted shares, up 12% from a year ago.

SHOE Total Shares

Q4 2023: 27MQ1 2024: 27MQ2 2024: 27MQ3 2024: 28MQ4 2024: 28MQ1 2025: 28MQ2 2025: 27MQ3 2025: 27MQ4 2025: 28MQ1 2026: 28MQ2 2026: 27MQ3 2026: 27M
Q4 2023: 27MQ1 2024: 27MQ2 2024: 27MQ3 2024: 28MQ4 2024: 28MQ1 2025: 28MQ2 2025: 27MQ3 2025: 27MQ4 2025: 28MQ1 2026: 28MQ2 2026: 27MQ3 2026: 27M
PeriodChange %Net change
Quarterly-0.3%-72K shares
1 year-0.5%-140K shares
3 years-0.3%-95K shares
5 years-4.7%-1.3M shares
Available history-6.2%-1.8M shares

SHOE has the edge over NIO on shareholder dilution, with a more favorable share count trend.

NIO Net Leverage

NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

SHOE Net Leverage

Q4 2023: -0.5xQ1 2024: -0.8xQ2 2024: -0.5xQ3 2024: -0.6xQ4 2024: -0.6xQ1 2025: -0.9xQ2 2025: -0.7xQ3 2025: -0.7xQ4 2025: -0.9xQ1 2026: -1.2xQ2 2026: -1.4xQ3 2026: -1.8x
Q4 2023: -0.5xQ1 2024: -0.8xQ2 2024: -0.5xQ3 2024: -0.6xQ4 2024: -0.6xQ1 2025: -0.9xQ2 2025: -0.7xQ3 2025: -0.7xQ4 2025: -0.9xQ1 2026: -1.2xQ2 2026: -1.4xQ3 2026: -1.8x
QuarterNet LeverageStatus
Q3 2026-1.8xNet Cash
Q2 2026-1.4xNet Cash
Q1 2026-1.2xNet Cash
Q4 2025-0.9xNet Cash
Q3 2025-0.7xNet Cash
Q2 2025-0.7xNet Cash
Q1 2025-0.9xNet Cash
Q4 2024-0.6xNet Cash

SHOE has more cash than debt.

NIO Weekly Momentum

MetricValueStatus
RSI30.7Neutral
Stochastic6.9Oversold

NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).

SHOE Weekly Momentum

MetricValueStatus
RSI45.4Neutral
Stochastic71.0Neutral

SHOE's weekly RSI is 45 (neutral) and its Stochastic is 71 (neutral).

NIO PE vs Consumer Cyclical Sector

NIO has no meaningful PE right now: it lost money over the past year.

SHOE PE vs Consumer Cyclical Sector

MetricSHOESector medianRelative
PE16x18x10% below
PE %854738 pts above

SHOE is trading at 16x earnings, a 10% discount to the Consumer Cyclical sector's median of 18x.

NIO Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.369.2% below
20 week MA$4.0124% below
50 week MA$4.8137% below
100 week MA$4.8537% below
200 week MA$6.0349% below

NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.

SHOE Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$13.73.6% above
20 week MA$14.20.1% below
50 week MA$16.614% below
100 week MA$19.226% below
200 week MA$24.742% below

SHOE has the edge over NIO on trend strength, trading above more of its moving averages.

NIO Yearly ROI

YearStart priceEnd priceROI
2020$2.42$45.8+1791%
2021$45.8$30.5-33%
2022$30.5$11.0-64%
2023$11.0$9.07-17%
2024$9.07$4.48-51%
2025$4.48$5.10+14%
2026 YTD$5.10$3.05-40%

NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.

SHOE Yearly ROI

YearStart priceEnd priceROI
2020$18.4$19.4+5.3%
2021$19.4$39.3+102%
2022$39.3$24.5-38%
2023$24.5$30.2+23%
2024$30.2$35.7+18%
2025$35.7$18.1-49%
2026 YTD$18.1$14.2-21%

SHOE has the edge over NIO on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key